nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—vagus nerve—obesity	0.075	0.268	CbGeAlD
Vapreotide—SSTR5—hindbrain—obesity	0.0512	0.183	CbGeAlD
Vapreotide—SSTR2—hindbrain—obesity	0.033	0.118	CbGeAlD
Vapreotide—SSTR5—pituitary gland—obesity	0.0212	0.0757	CbGeAlD
Vapreotide—SSTR5—endocrine gland—obesity	0.0164	0.0587	CbGeAlD
Vapreotide—SSTR2—pituitary gland—obesity	0.0137	0.0488	CbGeAlD
Vapreotide—TACR1—respiratory system—obesity	0.0134	0.0478	CbGeAlD
Vapreotide—SSTR2—digestive system—obesity	0.0128	0.0458	CbGeAlD
Vapreotide—SSTR2—endocrine gland—obesity	0.0106	0.0378	CbGeAlD
Vapreotide—TACR1—adipose tissue—obesity	0.00905	0.0323	CbGeAlD
Vapreotide—TACR1—digestive system—obesity	0.00852	0.0304	CbGeAlD
Vapreotide—TACR1—adrenal gland—obesity	0.00811	0.029	CbGeAlD
Vapreotide—TACR1—endocrine gland—obesity	0.00704	0.0251	CbGeAlD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CD—obesity	0.000121	0.000168	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—obesity	0.000121	0.000168	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PRKCB—obesity	0.000121	0.000167	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—F2—obesity	0.000121	0.000167	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NCF2—obesity	0.000119	0.000166	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HTR2A—obesity	0.000119	0.000166	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—C3—obesity	0.000119	0.000165	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—obesity	0.000119	0.000165	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CNR1—obesity	0.000119	0.000165	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRL—obesity	0.000119	0.000165	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STK11—obesity	0.000117	0.000162	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TCF7L2—obesity	0.000117	0.000162	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—obesity	0.000116	0.000162	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT2—obesity	0.000116	0.000161	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NPY—obesity	0.000116	0.000161	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—DRD2—obesity	0.000116	0.000161	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PLG—obesity	0.000116	0.000161	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOC3—obesity	0.000115	0.00016	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IAPP—obesity	0.000115	0.00016	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—RHOA—obesity	0.000115	0.00016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CG—obesity	0.000115	0.00016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTPN1—obesity	0.000115	0.000159	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GCG—obesity	0.000115	0.000159	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT2—obesity	0.000114	0.000159	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3R1—obesity	0.000114	0.000159	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGT—obesity	0.000113	0.000157	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FOXO3—obesity	0.000113	0.000157	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADRB2—obesity	0.000113	0.000156	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HTR1B—obesity	0.000112	0.000156	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CRH—obesity	0.000112	0.000156	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CD—obesity	0.000112	0.000155	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SOCS1—obesity	0.000111	0.000154	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SDC1—obesity	0.000111	0.000154	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PRKCD—obesity	0.000111	0.000154	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CD—obesity	0.00011	0.000153	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—obesity	0.00011	0.000153	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRL—obesity	0.00011	0.000152	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SOCS3—obesity	0.00011	0.000152	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKR1C3—obesity	0.000109	0.000151	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HTR2A—obesity	0.000108	0.00015	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—C3—obesity	0.000108	0.00015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STK11—obesity	0.000108	0.00015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—obesity	0.000107	0.000149	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNB3—obesity	0.000107	0.000149	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PLG—obesity	0.000107	0.000148	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—RHOA—obesity	0.000107	0.000148	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NPS—obesity	0.000106	0.000148	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TYK2—obesity	0.000106	0.000147	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT2—obesity	0.000106	0.000147	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CB—obesity	0.000105	0.000146	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3R1—obesity	0.000105	0.000146	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF2—obesity	0.000105	0.000146	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RHOA—obesity	0.000105	0.000146	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—F2—obesity	0.000104	0.000145	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PRKCB—obesity	0.000104	0.000145	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNAS—obesity	0.000104	0.000145	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DRD1—obesity	0.000104	0.000145	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HTR2C—obesity	0.000104	0.000145	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FOXO3—obesity	0.000104	0.000145	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADRB2—obesity	0.000104	0.000144	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3R1—obesity	0.000104	0.000144	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGT—obesity	0.000103	0.000143	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SOCS1—obesity	0.000102	0.000142	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOB—obesity	0.000102	0.000142	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CD—obesity	0.000101	0.000141	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NTRK2—obesity	0.000101	0.000141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SOCS3—obesity	0.000101	0.00014	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRB1—obesity	0.000101	0.00014	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CG—obesity	0.0001	0.000139	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL5—obesity	9.98e-05	0.000139	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNB3—obesity	9.89e-05	0.000137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PARP1—obesity	9.88e-05	0.000137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GHRL—obesity	9.88e-05	0.000137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DRD4—obesity	9.8e-05	0.000136	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LPL—obesity	9.76e-05	0.000136	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TYK2—obesity	9.75e-05	0.000135	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CB—obesity	9.73e-05	0.000135	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF2—obesity	9.72e-05	0.000135	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FOXO1—obesity	9.69e-05	0.000135	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RHOA—obesity	9.67e-05	0.000134	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RPS6KB1—obesity	9.67e-05	0.000134	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNAS—obesity	9.63e-05	0.000134	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CB—obesity	9.58e-05	0.000133	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3R1—obesity	9.57e-05	0.000133	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—obesity	9.52e-05	0.000132	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—F2—obesity	9.49e-05	0.000132	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PRKCB—obesity	9.49e-05	0.000132	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOB—obesity	9.43e-05	0.000131	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CNR1—obesity	9.36e-05	0.00013	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL5—obesity	9.21e-05	0.000128	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TCF7L2—obesity	9.19e-05	0.000128	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT2—obesity	9.15e-05	0.000127	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DRD2—obesity	9.13e-05	0.000127	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CG—obesity	9.08e-05	0.000126	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTPN1—obesity	9.04e-05	0.000126	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GCG—obesity	9.04e-05	0.000126	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LPL—obesity	9.01e-05	0.000125	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKCD—obesity	8.99e-05	0.000125	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FOXO1—obesity	8.94e-05	0.000124	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RPS6KB1—obesity	8.93e-05	0.000124	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CB—obesity	8.84e-05	0.000123	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HTR2A—obesity	8.8e-05	0.000122	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CD—obesity	8.79e-05	0.000122	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—C3—obesity	8.79e-05	0.000122	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—obesity	8.64e-05	0.00012	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRL—obesity	8.62e-05	0.00012	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STK11—obesity	8.5e-05	0.000118	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—obesity	8.46e-05	0.000117	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PLG—obesity	8.4e-05	0.000117	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—RHOA—obesity	8.39e-05	0.000117	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IRS2—obesity	8.36e-05	0.000116	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGT—obesity	8.35e-05	0.000116	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT2—obesity	8.31e-05	0.000115	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3R1—obesity	8.3e-05	0.000115	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKCD—obesity	8.3e-05	0.000115	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FOXO3—obesity	8.2e-05	0.000114	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOE—obesity	8.18e-05	0.000114	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LEP—obesity	8.18e-05	0.000114	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRB2—obesity	8.18e-05	0.000114	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HTR2A—obesity	8.12e-05	0.000113	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—C3—obesity	8.11e-05	0.000113	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CAV1—obesity	8.11e-05	0.000113	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOA1—obesity	8.09e-05	0.000112	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SOCS1—obesity	8.05e-05	0.000112	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CD—obesity	7.98e-05	0.000111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SOCS3—obesity	7.96e-05	0.000111	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ESR1—obesity	7.81e-05	0.000108	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNB3—obesity	7.79e-05	0.000108	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKCB—obesity	7.72e-05	0.000107	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IRS2—obesity	7.72e-05	0.000107	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—F2—obesity	7.72e-05	0.000107	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGT—obesity	7.71e-05	0.000107	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TYK2—obesity	7.68e-05	0.000107	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CB—obesity	7.66e-05	0.000106	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF2—obesity	7.65e-05	0.000106	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BAD—obesity	7.62e-05	0.000106	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RHOA—obesity	7.62e-05	0.000106	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNAS—obesity	7.58e-05	0.000105	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LEP—obesity	7.55e-05	0.000105	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOE—obesity	7.55e-05	0.000105	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3R1—obesity	7.54e-05	0.000105	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CAV1—obesity	7.48e-05	0.000104	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOA1—obesity	7.46e-05	0.000104	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOB—obesity	7.43e-05	0.000103	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CG—obesity	7.38e-05	0.000103	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IRS1—obesity	7.3e-05	0.000101	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL5—obesity	7.25e-05	0.000101	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ESR1—obesity	7.21e-05	0.0001	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—F2—obesity	7.12e-05	9.89e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKCB—obesity	7.12e-05	9.89e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LPL—obesity	7.09e-05	9.85e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FOXO1—obesity	7.04e-05	9.78e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BAD—obesity	7.04e-05	9.77e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—obesity	7.03e-05	9.76e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RPS6KB1—obesity	7.03e-05	9.76e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—INS—obesity	6.99e-05	9.71e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CB—obesity	6.96e-05	9.67e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—obesity	6.88e-05	9.55e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CG—obesity	6.81e-05	9.46e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1—obesity	6.76e-05	9.39e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT2—obesity	6.76e-05	9.38e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IRS1—obesity	6.74e-05	9.36e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCD—obesity	6.53e-05	9.08e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CD—obesity	6.49e-05	9.02e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—obesity	6.49e-05	9.01e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—INS—obesity	6.45e-05	8.96e-05	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—obesity	6.43e-05	8.93e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SERPINE1—obesity	6.42e-05	8.92e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HTR2A—obesity	6.39e-05	8.88e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—C3—obesity	6.38e-05	8.87e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—obesity	6.35e-05	8.81e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TYK2—obesity	6.24e-05	8.67e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1—obesity	6.24e-05	8.67e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT2—obesity	6.23e-05	8.66e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RHOA—obesity	6.19e-05	8.6e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOS3—obesity	6.13e-05	8.51e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3R1—obesity	6.13e-05	8.51e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IRS2—obesity	6.07e-05	8.44e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGT—obesity	6.07e-05	8.43e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CD—obesity	5.99e-05	8.32e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOE—obesity	5.94e-05	8.26e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LEP—obesity	5.94e-05	8.26e-05	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—obesity	5.93e-05	8.24e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SERPINE1—obesity	5.92e-05	8.23e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CAV1—obesity	5.89e-05	8.18e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOA1—obesity	5.88e-05	8.16e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—obesity	5.84e-05	8.11e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TYK2—obesity	5.76e-05	8e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RHOA—obesity	5.72e-05	7.94e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ESR1—obesity	5.68e-05	7.88e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MTOR—obesity	5.66e-05	7.86e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CB—obesity	5.66e-05	7.86e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3R1—obesity	5.66e-05	7.86e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOS3—obesity	5.66e-05	7.86e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—F2—obesity	5.61e-05	7.79e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCB—obesity	5.61e-05	7.79e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BAD—obesity	5.54e-05	7.69e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—obesity	5.39e-05	7.48e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CG—obesity	5.36e-05	7.45e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IRS1—obesity	5.3e-05	7.37e-05	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—obesity	5.25e-05	7.3e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CB—obesity	5.22e-05	7.25e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MTOR—obesity	5.22e-05	7.25e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—obesity	5.17e-05	7.18e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—obesity	5.11e-05	7.09e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—INS—obesity	5.08e-05	7.05e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—obesity	5e-05	6.94e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—obesity	4.92e-05	6.83e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1—obesity	4.91e-05	6.82e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT2—obesity	4.91e-05	6.82e-05	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—obesity	4.85e-05	6.73e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK8—obesity	4.78e-05	6.64e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—obesity	4.77e-05	6.63e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—obesity	4.77e-05	6.62e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CD—obesity	4.72e-05	6.55e-05	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—obesity	4.67e-05	6.49e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SERPINE1—obesity	4.66e-05	6.48e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—obesity	4.54e-05	6.3e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TYK2—obesity	4.54e-05	6.3e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RHOA—obesity	4.5e-05	6.25e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOS3—obesity	4.45e-05	6.19e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3R1—obesity	4.45e-05	6.19e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK8—obesity	4.41e-05	6.13e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—obesity	4.4e-05	6.11e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—obesity	4.37e-05	6.07e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—obesity	4.24e-05	5.89e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CB—obesity	4.11e-05	5.71e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MTOR—obesity	4.11e-05	5.71e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—obesity	4.06e-05	5.64e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—obesity	4.05e-05	5.63e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—obesity	4.03e-05	5.6e-05	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—obesity	3.82e-05	5.3e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—obesity	3.76e-05	5.22e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—obesity	3.75e-05	5.21e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—obesity	3.74e-05	5.2e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—obesity	3.57e-05	4.96e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK8—obesity	3.47e-05	4.83e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—obesity	3.47e-05	4.81e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—obesity	3.45e-05	4.79e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—obesity	3.18e-05	4.42e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—obesity	3.18e-05	4.41e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—obesity	3.05e-05	4.24e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—obesity	2.95e-05	4.1e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—obesity	2.94e-05	4.09e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—obesity	2.82e-05	3.91e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—obesity	2.82e-05	3.91e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—obesity	2.6e-05	3.61e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—obesity	2.51e-05	3.48e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—obesity	2.22e-05	3.08e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—obesity	2.05e-05	2.84e-05	CbGpPWpGaD
